Lambda CovidVariant  may be a emerging threat

Lambda CovidVariant  may be a emerging threat

Subject : Science & tech

Context: Amid Delta variant of the SARS-CoV-2 coronavirus continues to drive the rise in infections around the world, another variant, Lambda, is increasingly being seen by scientists and health experts as a new emerging threat.

Concept :

Lambda Covid Variant

• It is previously known by its formal scientific name C.37.
• In June 2021, the World Health Organization has designated the Lambda variant, as the seventh and newest “variant of interest”.
• It has been the dominant variant in Peru and other countries of South America.
• The Lambda variant has not yet been found in the Indian population, but has been detected in the UK and other European countries.

Mutations in Lambda Covid Variant

• According to the WHO, the Lambda variant has at least seven significant mutations in the spike protein (the Delta variant has three).
• It could have a range of implications, including the possibility of increased transmissibility or enhanced resistance to antibodies, created either through natural infection or vaccination.
• It had greater infectivity than the Alpha and Gamma variants (known to have originated in the UK and Brazil respectively).
• The study by researchers at the Chile reported decreased effectiveness of the Chinese Sinovac vaccine (Coronavac) against the Lambda variant.

What does ‘variant of interest’ designation mean?

• It implies that the genetic changes involved are predicted or known to affect transmissibility, disease severity, or immune escape.
• It is an acknowledgement of the fact that the variant has caused significant community transmission in multiple countries and population groups.
• There are currently seven variants, including the Lambda that the WHO classifies as “variants of interest”.